These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 35138228)

  • 1. An initial exploration of the convergent and ecological validity of the UDS 3.0 neuropsychological battery in Parkinson's Disease.
    Lea R; Benge JF; Adler CH; Beach TG; Belden CM; Zhang N; Shill HA; Driver-Dunckley E; Mehta SH; Atri A
    J Clin Exp Neuropsychol; 2021 Nov; 43(9):918-925. PubMed ID: 35138228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ecological validity of the Uniform Data Set 3.0 neuropsychological battery in individuals with mild cognitive impairment and dementia.
    Benge JF; Artz JD; Kiselica AM
    Clin Neuropsychol; 2022 Aug; 36(6):1453-1470. PubMed ID: 33103615
    [No Abstract]   [Full Text] [Related]  

  • 3. A time-efficient screening tool for activities of daily living functions in Parkinson's disease dementia.
    Sulzer P; Liebig L; Csoti I; Graessel E; Wurster I; Berg D; Liepelt-Scarfone I
    J Clin Exp Neuropsychol; 2020 Oct; 42(8):867-879. PubMed ID: 33043797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantifying activities of daily living impairment in Parkinson's disease using the Functional Activities Questionnaire.
    Becker S; Pauly C; Lawton M; Hipp G; Bowring F; Sulzer P; Hu M; Krüger R; Gasser T; Liepelt-Scarfone I
    Neurol Sci; 2022 Feb; 43(2):1047-1054. PubMed ID: 34109514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Cognitive-Driven Performance-Based Activities of Daily Living Dysfunction in Parkinson's Disease.
    Sulzer P; Bäumer A; Hoang HG; Becker S; Lönneker HD; Graessel E; Liepelt-Scarfone I
    J Int Neuropsychol Soc; 2020 Apr; 26(4):430-440. PubMed ID: 31822319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of cognitive activities of daily living (ADL) function and nonmotor burden in nondemented Parkinson's disease patients.
    Becker S; Bäumer A; Maetzler W; Nussbaum S; Tkaczynska Z; Sulzer P; Timmers M; Van Nueten L; Salvadore G; Brockmann K; Streffer J; Berg D; Liepelt-Scarfone I
    Neuropsychology; 2020 May; 34(4):447-455. PubMed ID: 32191056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of cognitive-driven activity of daily living impairment in non-demented Parkinson's patients.
    Becker S; Bäumer A; Maetzler W; Nussbaum S; Timmers M; Van Nueten L; Salvadore G; Zaunbrecher D; Roeben B; Brockmann K; Streffer J; Berg D; Liepelt-Scarfone I
    J Neuropsychol; 2020 Mar; 14(1):69-84. PubMed ID: 30320954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychometric Properties of the Clinical Dementia Rating Scale Sum of Boxes in Parkinson's Disease.
    Gallagher J; Rick J; Xie SX; Martinez-Martin P; Mamikonyan E; Chen-Plotkin A; Dahodwala N; Morley J; Duda JE; Trojanowski JQ; Siderowf A; Weintraub D
    J Parkinsons Dis; 2021; 11(2):737-745. PubMed ID: 33386814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smartphone-Based Neuropsychological Assessment in Parkinson's Disease: Feasibility, Validity, and Contextually Driven Variability in Cognition.
    Weizenbaum EL; Fulford D; Torous J; Pinsky E; Kolachalama VB; Cronin-Golomb A
    J Int Neuropsychol Soc; 2022 Apr; 28(4):401-413. PubMed ID: 33998438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond PD-MCI: objectively defined subtle cognitive decline predicts future cognitive and functional changes.
    Jones JD; Uribe C; Bunch J; Thomas KR
    J Neurol; 2021 Jan; 268(1):337-345. PubMed ID: 32804281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new device-aided cognitive function test, User eXperience-Trail Making Test (UX-TMT), sensitively detects neuropsychological performance in patients with dementia and Parkinson's disease.
    Kokubo N; Yokoi Y; Saitoh Y; Murata M; Maruo K; Takebayashi Y; Shinmei I; Yoshimoto S; Horikoshi M
    BMC Psychiatry; 2018 Jul; 18(1):220. PubMed ID: 29976167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Responsiveness to Change of the Montreal Cognitive Assessment, Mini-Mental State Examination, and SCOPA-Cog in Non-Demented Patients with Parkinson's Disease.
    Faust-Socher A; Duff-Canning S; Grabovsky A; Armstrong MJ; Rothberg B; Eslinger PJ; Meaney CA; Schneider RB; Tang-Wai DF; Fox SH; Zadikoff C; Kennedy N; Chou KL; Persad C; Litvan I; Mast BT; Gerstenecker AT; Weintraub S; Reginold W; Marras C
    Dement Geriatr Cogn Disord; 2019; 47(4-6):187-197. PubMed ID: 31315127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reliability, validity, and diagnostic accuracy of Parkinson's Disease-Cognitive Rating Scale in Iranian patients with idiopathic Parkinson's disease.
    Mahmoudi Asl A; Mehdizadeh M; Kulisevsky J; Sabet A; Taghavi Azar Sharabiani P; Mehdizadeh H; Ashayeri H; Taghizadeh G
    Disabil Rehabil; 2022 May; 44(10):2091-2098. PubMed ID: 32924645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Instrumental activities of daily living are impaired in Parkinson's disease patients with mild cognitive impairment.
    Pirogovsky E; Schiehser DM; Obtera KM; Burke MM; Lessig SL; Song DD; Litvan I; Filoteo JV
    Neuropsychology; 2014 Mar; 28(2):229-37. PubMed ID: 24417192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease.
    Besser LM; Litvan I; Monsell SE; Mock C; Weintraub S; Zhou XH; Kukull W
    Parkinsonism Relat Disord; 2016 Jun; 27():54-60. PubMed ID: 27089852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid communication: Preliminary validation of a telephone adapted Montreal Cognitive Assessment for the identification of mild cognitive impairment in Parkinson's disease.
    Benge JF; Kiselica AM
    Clin Neuropsychol; 2021 Jan; 35(1):133-147. PubMed ID: 32779959
    [No Abstract]   [Full Text] [Related]  

  • 17. A Comparison of Functional Abilities in Individuals with Mild Cognitive Impairment and Parkinson's Disease with Mild Cognitive Impairment Using Multiple Assessment Methods.
    Schmitter-Edgecombe M; McAlister C; Greeley D
    J Int Neuropsychol Soc; 2022 Sep; 28(8):798-809. PubMed ID: 34486508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An assessment of Movement Disorder Society Task Force diagnostic criteria for mild cognitive impairment in Parkinson's disease.
    Uysal-Cantürk P; Hanağası HA; Bilgiç B; Gürvit H; Emre M
    Eur J Neurol; 2018 Jan; 25(1):148-153. PubMed ID: 28941002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkinson's Disease--Cognitive Functional Rating Scale across different conditions and degrees of cognitive impairment.
    Ruzafa-Valiente E; Fernández-Bobadilla R; García-Sánchez C; Pagonabarraga J; Martínez-Horta S; Kulisevsky J
    J Neurol Sci; 2016 Feb; 361():66-71. PubMed ID: 26810519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and screening power of neuropsychological testing in detecting mild cognitive impairment in Parkinson's disease.
    Biundo R; Weis L; Pilleri M; Facchini S; Formento-Dojot P; Vallelunga A; Antonini A
    J Neural Transm (Vienna); 2013 Apr; 120(4):627-33. PubMed ID: 23483334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.